AI and computational modeling are reducing reliance on animal testing by simulating human biology, improving drug safety and ...

Businesses want to be available to provide for employees and be competitive. They want workers to be able to go to the HR ...

In today’s Pharmaceutical Executive Daily, learn how Tesaro is suing AnaptysBio over alleged contract breaches, Flagship ...

Moderna secured a $1.5 billion loan from Ares Management, structured in three tranches, to support financial flexibility and ...

Amid the usual hustle before a big medical conference or industry trade show, editors are often buried under a flood of news ...

Following the company’s announcement of lackluster results from both its Phase III trials, Novo’s shares dropped nearly 9% pre-market, a significant shift the company hasn’t seen in its shares since ...